Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated wit...
Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab’ by Avouac et al
About this item
Full title
Author / Creator
Publisher
England: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
A singular profile of patients with both autoimmune disease and COVID-19 has not yet emerged, and each patient may be a special case when faced with COVID-19, considering the gathering and interplay of pathophysiological mechanisms and clinical features of the rheumatic disease, comorbidities,2 viral aggression and immune response against coronavir...
Alternative Titles
Full title
Response to: ‘Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab’ by Avouac et al
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_03601679v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_03601679v1
Other Identifiers
ISSN
0003-4967,1468-2060
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2020-217955
